NCT04883606View on ClinicalTrials.gov

A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

July 24, 2023

Study Completion Date

July 24, 2023

Conditions
Short Bowel Syndrome
Trial Locations (1)

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04883606 - A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome | Biotech Hunter | Biotech Hunter